2009
DOI: 10.1017/s0031182009991132
|View full text |Cite
|
Sign up to set email alerts
|

Whole genome amplification (WGA) for archiving and genotyping of clinical isolates ofCryptosporidiumspecies

Abstract: S U M M A R YClinical and environmental isolates of pathogens are often unique and may be unculturable, yielding a very limited amount of DNA for genetic studies. Cryptosporidium in particular are difficult to propagate. Whole genome amplification (WGA) is a valuable technique for amplifying genomic material. In this study, we tested 5 WGA commercial kits using Cryptosporidium clinical isolates. DNA of 5 C. hominis and 5 C. parvum clinical isolates and C. parvum IOWA reference strain were used. The majority of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 42 publications
(51 reference statements)
1
11
0
Order By: Relevance
“…The yield of amplified DNA, quantified by PicoGreen, was lower than the manufacturer's claim (10 μg per reaction), ranging from 0.8 to 1.2 μg in a 50 μL final volume corresponding to a 115–170‐fold amplification. This is coherent with the 50–160‐fold amplification obtained for bacteria with the REPLI‐g Mini kit (Bouzid et al , 2009; Woyke et al , 2009).…”
Section: Discussionsupporting
confidence: 83%
“…The yield of amplified DNA, quantified by PicoGreen, was lower than the manufacturer's claim (10 μg per reaction), ranging from 0.8 to 1.2 μg in a 50 μL final volume corresponding to a 115–170‐fold amplification. This is coherent with the 50–160‐fold amplification obtained for bacteria with the REPLI‐g Mini kit (Bouzid et al , 2009; Woyke et al , 2009).…”
Section: Discussionsupporting
confidence: 83%
“…In addition, reference primers Cry15 and Cry9 amplifying a 555 bp of the COWP gene [23] were used as a positive control. PCR conditions were carried out as described previously [40]. PCR screening of putative species genes was performed by testing a panel of DNA clinical samples isolated as described previously [41] and archived in the national collection at the UK Cryptosporidium Reference Unit (CRU) [42].…”
Section: Methodsmentioning
confidence: 99%
“…Consequently, the amount of genomic DNA extracted from the purified oocysts is limited. To increase DNA concentrations for NGS library construction, we have used WGA to amplify extracted DNA, as already done for archiving Cryptosporidium DNA from clinical specimens (19). Although the visualization of genomic DNA of high molecular weight by electrophoresis is a direct demonstration of successes and failures in genome amplification, we used ssrRNA gene-based qPCR to assess the quality and quality of the Cryptosporidium DNA amplified, indicated by the C T values generated (Fig.…”
Section: Figmentioning
confidence: 99%